Taken together, these results revealed that baicalin may intervene in the treatment of COVID-19-related CS through multiple immune target signaling pathways, in which NF-κB may be the main key target downstream of each signaling pathway. The gene discussed is NFKB1; the disease is Cowden syndrome 1.